CLINICAL_TRIALS
trial_result
· 2014-06-17
Clinical Trial Update: 12 / 48 wk Pivotal PFT vs PBO in COPD II [Phase 3]
Summary
Boehringer Ingelheim conducted a pivotal Phase 3 trial comparing PFT to placebo in chronic obstructive pulmonary disease. The results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2014-06-17